日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mechanical Versus Restrictive Kinematic Alignment in Robotic-Assisted Total Knee Arthroplasty: A Randomized Controlled Trial

机器人辅助全膝关节置换术中机械式与限制式运动学对线:一项随机对照试验

Lychagin, Alexey V; Gritsyuk, Andrey A; Elizarov, Mikhail P; Gritsuk, Andrey A Jr; Gavlovsky, Maxim Y; Tomboidi, Konstantin K; Kalinsky, Eugene B; Rosenberg, Nahum

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

转移性三阴性乳腺癌患者 sacituzumab govitecan 与化疗对比的 III 期 ASCENT 研究中生物标志物分析

A Bardia, S M Tolaney, K Punie, D Loirat, M Oliveira, K Kalinsky, A Zelnak, P Aftimos, F Dalenc, S Sardesai, E Hamilton, P Sharma, S Recalde, E C Gil, T Traina, J O'Shaughnessy, J Cortes, M Tsai, L Vahdat, V Diéras, L A Carey, H S Rugo, D M Goldenberg, Q Hong, M Olivo, L M Itri, S A Hurvitz

Diffuse optical tomography of the breast: a potential modifiable biomarker of breast cancer risk with neoadjuvant chemotherapy

乳腺弥散光学断层扫描:一种潜在的、可通过新辅助化疗改变的乳腺癌风险生物标志物

Altoe, Mirella L; Marone, Alessandro; Kim, Hyun K; Kalinsky, Kevin; Hershman, Dawn L; Hielscher, Andreas H; Ha, Richard S

Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial

AKT 抑制剂 MK-2206 对可手术浸润性乳腺癌患者的术前试验:纽约癌症联盟试验

K Kalinsky, J A Sparano, X Zhong, E Andreopoulou, B Taback, L Wiechmann, S M Feldman, P Ananthakrishnan, A Ahmad, S Cremers, A N Sireci, J R Cross, D K Marks, P Mundi, E Connolly, K D Crew, M A Maurer, H Hibshoosh, S Lee, D L Hershman

Proteomic modulation in breast tumors after metformin exposure: results from a "window of opportunity" trial

二甲双胍暴露后乳腺肿瘤的蛋白质组调节:“机会之窗”试验的结果

K Kalinsky, T Zheng, H Hibshoosh, X Du, P Mundi, J Yang, S Refice, S M Feldman, B Taback, E Connolly, K D Crew, M A Maurer, D L Hershman